Global Cerebrovascular Disease Market Size, Status and Forecast 2019-2025

2019-01-14 / 3900.00 / Pharma & Healthcare / 94 Pages

Description

Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
In 2018, the global Cerebrovascular Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cerebrovascular Disease development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
...

Market segment by Type, the product can be split into
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

Market segment by Application, split into
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players.
To present the Cerebrovascular Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cerebrovascular Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cerebrovascular Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Carotid Endarterectomy
1.4.3 Carotid Angioplasty Or Carotid Artery Stenting
1.4.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.5 Market by Application
1.5.1 Global Cerebrovascular Disease Market Share by Application (2014-2025)
1.5.2 Academic & Research Institutes
1.5.3 Pharmaceutical & Biotechnology Companies
1.5.4 Hospitals & Diagnostic Centers
1.5.5 Contract Research Organizations
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cerebrovascular Disease Market Size
2.2 Cerebrovascular Disease Growth Trends by Regions
2.2.1 Cerebrovascular Disease Market Size by Regions (2014-2025)
2.2.2 Cerebrovascular Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cerebrovascular Disease Market Size by Manufacturers
3.1.1 Global Cerebrovascular Disease Revenue by Manufacturers (2014-2018)
3.1.2 Global Cerebrovascular Disease Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
3.2 Cerebrovascular Disease Key Players Head office and Area Served
3.3 Key Players Cerebrovascular Disease Product/Solution/Service
3.4 Date of Enter into Cerebrovascular Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cerebrovascular Disease Market Size by Type (2014-2019)
4.2 Global Cerebrovascular Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Cerebrovascular Disease Market Size (2014-2019)
5.2 Cerebrovascular Disease Key Players in United States
5.3 United States Cerebrovascular Disease Market Size by Type
5.4 United States Cerebrovascular Disease Market Size by Application

6 Europe
6.1 Europe Cerebrovascular Disease Market Size (2014-2019)
6.2 Cerebrovascular Disease Key Players in Europe
6.3 Europe Cerebrovascular Disease Market Size by Type
6.4 Europe Cerebrovascular Disease Market Size by Application

7 China
7.1 China Cerebrovascular Disease Market Size (2014-2019)
7.2 Cerebrovascular Disease Key Players in China
7.3 China Cerebrovascular Disease Market Size by Type
7.4 China Cerebrovascular Disease Market Size by Application

8 Japan
8.1 Japan Cerebrovascular Disease Market Size (2014-2019)
8.2 Cerebrovascular Disease Key Players in Japan
8.3 Japan Cerebrovascular Disease Market Size by Type
8.4 Japan Cerebrovascular Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cerebrovascular Disease Market Size (2014-2019)
9.2 Cerebrovascular Disease Key Players in Southeast Asia
9.3 Southeast Asia Cerebrovascular Disease Market Size by Type
9.4 Southeast Asia Cerebrovascular Disease Market Size by Application

10 India
10.1 India Cerebrovascular Disease Market Size (2014-2019)
10.2 Cerebrovascular Disease Key Players in India
10.3 India Cerebrovascular Disease Market Size by Type
10.4 India Cerebrovascular Disease Market Size by Application

11 Central & South America
11.1 Central & South America Cerebrovascular Disease Market Size (2014-2019)
11.2 Cerebrovascular Disease Key Players in Central & South America
11.3 Central & South America Cerebrovascular Disease Market Size by Type
11.4 Central & South America Cerebrovascular Disease Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cerebrovascular Disease Introduction
12.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cerebrovascular Disease Introduction
12.2.4 Amgen Revenue in Cerebrovascular Disease Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cerebrovascular Disease Introduction
12.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cerebrovascular Disease Introduction
12.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2014-2019)
12.4.5 Sanofi-Aventis Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cerebrovascular Disease Introduction
12.5.4 Merck Revenue in Cerebrovascular Disease Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Sangamo BioSciences
12.6.1 Sangamo BioSciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cerebrovascular Disease Introduction
12.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2014-2019)
12.6.5 Sangamo BioSciences Recent Development
12.7 Aldagen
12.7.1 Aldagen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cerebrovascular Disease Introduction
12.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2014-2019)
12.7.5 Aldagen Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Cerebrovascular Disease Key Market Segments
Table Key Players Cerebrovascular Disease Covered
Table Global Cerebrovascular Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cerebrovascular Disease Market Size Market Share by Type 2014-2025
Figure Carotid Endarterectomy Figures
Table Key Players of Carotid Endarterectomy
Figure Carotid Angioplasty Or Carotid Artery Stenting Figures
Table Key Players of Carotid Angioplasty Or Carotid Artery Stenting
Figure Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Figures
Table Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Table Global Cerebrovascular Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic & Research Institutes Case Studies
Figure Pharmaceutical & Biotechnology Companies Case Studies
Figure Hospitals & Diagnostic Centers Case Studies
Figure Contract Research Organizations Case Studies
Figure Others Case Studies
Figure Cerebrovascular Disease Report Years Considered
Table Global Cerebrovascular Disease Market Size 2014-2025 (Million US$)
Figure Global Cerebrovascular Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cerebrovascular Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Cerebrovascular Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Cerebrovascular Disease Market Share by Regions 2014-2019
Figure Global Cerebrovascular Disease Market Share by Regions 2014-2019
Figure Global Cerebrovascular Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Cerebrovascular Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cerebrovascular Disease Market Share by Manufacturers (2014-2019)
Figure Global Cerebrovascular Disease Market Share by Manufacturers in 2018
Table Global Cerebrovascular Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cerebrovascular Disease Product/Solution/Service
Table Date of Enter into Cerebrovascular Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table Global Cerebrovascular Disease Market Size Share by Type (2014-2019)
Figure Global Cerebrovascular Disease Market Size Market Share by Type (2014-2019)
Table Global Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table Global Cerebrovascular Disease Market Size Share by Application (2014-2019)
Figure Global Cerebrovascular Disease Market Size Market Share by Application (2014-2019)
Figure Global Cerebrovascular Disease Revenue Market Share by Application in 2018
Figure United States Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Cerebrovascular Disease Market Share (2018-2019)
Table United States Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table United States Cerebrovascular Disease Market Share by Type (2014-2019)
Table United States Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table United States Cerebrovascular Disease Market Share by Application (2014-2019)
Figure Europe Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Cerebrovascular Disease Market Share (2018-2019)
Table Europe Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Cerebrovascular Disease Market Share by Type (2014-2019)
Table Europe Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Cerebrovascular Disease Market Share by Application (2014-2019)
Figure China Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table China Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table China Key Players Cerebrovascular Disease Market Share (2018-2019)
Table China Cerebrovascular Disease Market Size by Type (2014-20189) (Million US$)
Table China Cerebrovascular Disease Market Share by Type (2014-2019)
Table China Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table China Cerebrovascular Disease Market Share by Application (2014-2019)
Figure Japan Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Cerebrovascular Disease Market Share (2018-2019)
Table Japan Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Cerebrovascular Disease Market Share by Type (2014-2019)
Table Japan Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Cerebrovascular Disease Market Share by Application (2014-2019)
Figure Southeast Asia Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cerebrovascular Disease Market Share (2018-2019)
Table Southeast Asia Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cerebrovascular Disease Market Share by Type (2014-2019)
Table Southeast Asia Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cerebrovascular Disease Market Share by Application (2014-2019)
Figure India Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table India Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table India Key Players Cerebrovascular Disease Market Share (2018-2019)
Table India Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table India Cerebrovascular Disease Market Share by Type (2014-2019)
Table India Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table India Cerebrovascular Disease Market Share by Application (2014-2019)
Figure Central & South America Cerebrovascular Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cerebrovascular Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cerebrovascular Disease Market Share (2018-2019)
Table Central & South America Cerebrovascular Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cerebrovascular Disease Market Share by Type (2014-2019)
Table Central & South America Cerebrovascular Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cerebrovascular Disease Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cerebrovascular Disease Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Amgen Company Details
Table Amgen Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Amgen Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Sanofi-Aventis Recent Development
Table Merck Company Details
Table Merck Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Merck Recent Development
Table Sangamo BioSciences Company Details
Table Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Sangamo BioSciences Recent Development
Table Aldagen Company Details
Table Aldagen Revenue in Cerebrovascular Disease Business (2014-2019)(Million US$)
Figure Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2014-2019)
Table Aldagen Recent Development
Table Global Cerebrovascular Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Cerebrovascular Disease Market Size Share by Regions (2019-2025)
Figure Global Cerebrovascular Disease Market Size Share by Regions in 2025
Figure United States Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cerebrovascular Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Cerebrovascular Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Cerebrovascular Disease Market Size by Product (2019-2025)
Figure Global Cerebrovascular Disease Market Size by Product in 2025
Table Global Cerebrovascular Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Cerebrovascular Disease Market Size by Application (2019-2025)
Figure Global Cerebrovascular Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory